Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Nieuw veiligheidsprobleem bij HBV/HCV-co-infectie
okt 2017 | Hepatitis